These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17139107)

  • 1. Mono- and dihydroxylated metabolites of thalidomide: synthesis and TNF-alpha production-inhibitory activity.
    Nakamura T; Noguchi T; Kobayashi H; Miyachi H; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2006 Dec; 54(12):1709-14. PubMed ID: 17139107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolyzed metabolites of thalidomide: synthesis and TNF-alpha production-inhibitory activity.
    Nakamura T; Noguchi T; Miyachi H; Hashimoto Y
    Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):651-4. PubMed ID: 17409565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production.
    Muller GW; Chen R; Huang SY; Corral LG; Wong LM; Patterson RT; Chen Y; Kaplan G; Stirling DI
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1625-30. PubMed ID: 10386948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-alpha production is associated with a change of mechanism of action.
    Niwayama S; Loh C; Turk BE; Liu JO; Miyachi H; Hashimoto Y
    Bioorg Med Chem Lett; 1998 May; 8(9):1071-6. PubMed ID: 9871710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, configurational stability and stereochemical biological evaluations of (S)- and (R)-5-hydroxythalidomides.
    Yamamoto T; Shibata N; Sukeguchi D; Takashima M; Nakamura S; Toru T; Matsunaga N; Hara H; Tanaka M; Obata T; Sasaki T
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3973-6. PubMed ID: 19297157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering a new analogue of thalidomide which may be used as a potent modulator of TNF-alpha production.
    Fernández Braña M; Acero N; Añorbe L; Muñoz Mingarro D; Llinares F; Domínguez G
    Eur J Med Chem; 2009 Sep; 44(9):3533-42. PubMed ID: 19394719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aza analogues of thalidomide: synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro.
    Gütschow M; Hecker T; Thiele A; Hauschildt S; Eger K
    Bioorg Med Chem; 2001 Apr; 9(4):1059-65. PubMed ID: 11354662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents.
    El-Zahabi MA; Sakr H; El-Adl K; Zayed M; Abdelraheem AS; Eissa SI; Elkady H; Eissa IH
    Bioorg Chem; 2020 Nov; 104():104218. PubMed ID: 32932121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide analogs from diamines: Synthesis and evaluation as inhibitors of TNF-alpha production.
    de Almeida MV; Teixeira FM; de Souza MV; Amarante GW; Alves CC; Cardoso SH; Mattos AM; Ferreira AP; Teixeira HC
    Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):223-6. PubMed ID: 17268092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity.
    Zhu X; Giordano T; Yu QS; Holloway HW; Perry TA; Lahiri DK; Brossi A; Greig NH
    J Med Chem; 2003 Nov; 46(24):5222-9. PubMed ID: 14613324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of tumor necrosis factor-alpha production by tetrafluorothalidomide and tetrafluorophthalimides.
    Niwayama S; Turk BE; Liu JO
    J Med Chem; 1996 Aug; 39(16):3044-5. PubMed ID: 8759624
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity.
    Muller GW; Corral LG; Shire MG; Wang H; Moreira A; Kaplan G; Stirling DI
    J Med Chem; 1996 Aug; 39(17):3238-40. PubMed ID: 8765505
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha production enhancing activity of substituted 3'-methylthalidomide: influence of substituents at the phthaloyl moiety on the activity and stereoselectivity.
    Miyachi H; Koiso Y; Shirai R; Niwayama S; Liu JO; Hashimoto Y
    Chem Pharm Bull (Tokyo); 1998 Jul; 46(7):1165-8. PubMed ID: 9692223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of thalidomide and phthalimide esters as antitumor agents.
    Zahran MA; Abdin YG; Osman AM; Gamal-Eldeen AM; Talaat RM; Pedersen EB
    Arch Pharm (Weinheim); 2014 Sep; 347(9):642-9. PubMed ID: 24943104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biological response modifiers derived from thalidomide.
    Hashimoto Y
    Curr Med Chem; 1998 Jun; 5(3):163-78. PubMed ID: 9562600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumor metastasis.
    Shah JH; Swartz GM; Papathanassiu AE; Treston AM; Fogler WE; Madsen JW; Green SJ
    J Med Chem; 1999 Aug; 42(16):3014-7. PubMed ID: 10447943
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulators of tumor necrosis factor alpha production bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
    Tsuji M; Koiso Y; Takahashi H; Hashimoto Y; Endo Y
    Biol Pharm Bull; 2000 Apr; 23(4):513-6. PubMed ID: 10784439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.
    Corral LG; Muller GW; Moreira AL; Chen Y; Wu M; Stirling D; Kaplan G
    Mol Med; 1996 Jul; 2(4):506-15. PubMed ID: 8827720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.
    Chaulet C; Croix C; Alagille D; Normand S; Delwail A; Favot L; Lecron JC; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1019-22. PubMed ID: 21215621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical stabilities and biological activities of thalidomide and its N-alkyl analogs.
    Goosen C; Laing TJ; du Plessis J; Goosen TC; Rao TB; Flynn GL
    Pharm Res; 2002 Aug; 19(8):1232-5. PubMed ID: 12240951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.